Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Pilot and Feasibility Studies|November 14, 2019
A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching toolHala T Borno, Brian M Bakke, Celia Kaplan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Circulation. Cardiovascular Quality and Outcomes|November 12, 2015
Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized TrialStephen D Persell, Tiffany Brown, Ji Young Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two PracticesAmrita D Singh, Sapna Parmar, Khilna Patel, et al.
EMBO Molecular Medicine|December 28, 2020
MicroRNA-574 regulates FAM210A expression and influences pathological cardiac remodelingJiangbin Wu, Kadiam C Venkata Subbaiah, Feng Jiang, et al.
JAMA Network Open|March 20, 2024
Artificial Intelligence-Generated Draft Replies to Patient Inbox MessagesPatricia Garcia, Stephen P Ma, Shreya Shah, et al.
Investigational New Drugs|March 26, 2010
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortiumDeborah A Bradley, Stephanie Daignault, Charles J Ryan, et al.
The Lancet. Oncology|November 3, 2023
Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trialRahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Journal of General Internal Medicine|November 12, 2024
Recommendations for Clinicians, Technologists, and Healthcare Organizations on the Use of Generative Artificial Intelligence in Medicine: A Position Statement from the Society of General Internal MedicineByron Crowe, Shreya Shah, Derek Teng, et al.
Urologic Oncology|July 26, 2021
A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II studyYaoYao Pollock, Li Zhang, Stacey A Kenfield, et al.
Pageof 10